Human breast cancer cells (MDA-MB-231 cells) that have a high CD44 expression possess a potential activity of MMPs that facilitates invasiveness and CD44 depletion attenuated cell invasion through the reduction of collagen degrading enzymes (Montgomery et al., 2012). This evidence concerns the gene CD44 and breast cancer.